The importance of patent scope: An empirical analysis

RAND Journal of Economics

Volumn 25, Issue 2, 1994, Pages 319-333

  Lerner, Joshua ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 21344491476     PISSN: 07416261     EISSN: 17562171     Source Type: Journal    
DOI: 10.2307/2555833     Document Type: Article

References (51)

1. American Intelleclual Property Law Association. Biotechnology Litigation Report, No. 3, New York: American Intellectual Property Law Association, 1993.
2. AUSTIN, D . H . "An Event-Study Approach to Measuring Innovative Output: The Case of Biotechnology." American Economic Review Papers and Proceedings, Vol. 83 (1993), pp. 253-258 .
3. BLUME, M.E. AND STAMBAUGH, R.F. "Biases in Computed Returns: An Application to the Size Effect." Journal of Financial Economics, Vol. 12 (1983), pp. 387-404.
4. BRS Information Technologies. " PAT DATA . " Mimeo, BRS Information Technologies. McLean, VA: 1986 .
5. CAREY, J. AND HAMILTON, JO. "Genentech: A David that Comes on Like Goliath." Business Week, October 30, 1989, p. 165.
6. COCKBURN, I . AND GRILICHES, Z . "Industry Effects and Appropriability Measures in the Stock Market's Valuation of R & D and Patents." American Economic Review Papers and Proceedings, Vol. 78 (1988), pp. 419-423.
7. Committee on Japan, Office of Japan Affairs, National Research Council. "Workshop on Intellectual Property Rights and U.S.-Japan Competition in Biotechnology, January 18, 1991." Mimeo, National Research Council, 1991 .
8. GILBERT, R.J. AND SHAPIRO, C. "Optimal Patent Length and Breadth." RAND Journal of Economics, Vol. 21 (1990), pp. 106-112 .
9. GREEN, J.R. AND SCOTCMMER, S. "Antitrust Policy, the Breadth of Patent Protection and the Incentive to Develop New Products." Working Paper no. 172, University of California at Berkeley, Graduate School of Public-Policy, 1990.
10. GRILICHES, Z . "Market Value, R&D and Patents." Economics Utters, Vol. 7 (1981), pp. 183-187.
11. "Patent Statistics as Economic Indicators: A Survey." Journal ofEconomic Literature, Vol. 28 (1990), pp. 1661-1707.
12. JUDGE, G . G ., GRIFFITHS, W.E., HILL, R.C., LUETKEPOHL, H ., AND LEE, T.-C. The Theory and Practice of Econometrics. New York: John Wiley and Sons, 1985.
13. KENNEY, M . Biotechnology: The University-Industrial Complex. New Haven, Conn.: Yale University Press, 1986.
14. KLEMPERER, P. "HOW Broad Should the Scope of Patent Protection Be?" RAND Journal of Economics, Vol. 21 (1990), pp. 113-130.
15. Ko, Y. "An Economic Analysis of Biotechnology Patent Protection." Yale Law Journal, Vol. 102 (1992), pp. 777-804.
16. KOLATA, G . "In Rush to Patent Genes, Claims Get Smaller." New York Times, September 6, 1992, p. E12.
17. KUNZE, R.J. Nothing Ventured: The Perils and Payoffs of the Great American Venture Capital Game. New York: Harper Business, 1990.
18. KUSHAN, J.P. "Protein Patents and the Doctrine of Equivalents: Limits on the Expansion of Patent Rights." High Technology Law Journal, Vol. 6 (1991), pp. 109-148.
19. LENTZ, E.T. "Adequacy of Disclosures of Biotechnology Inventions." AIPLA Quarterly Journal, Vol. 16 (1988), pp. 314-338.
20. LERNER, T. Biorelationships: A Guide to Business Relationships Involving Biotechnology Companies and their Corporate Partners. New York: Shearson Lehman Hutton, 1989.
21. MADDALA, G . S . Limited-Dependent and Qualitative Variables in Econometrics. New York: Cambridge University Press, 1983.
22. MANSFIELD, E. " R & D and Innovation: Some Empirical Findings." In Z. Griliches, ed., R&D, Patents, and Productivity. Chicago: University of Chicago Press, 1984.
23. MATUTES, C, REGIBEAU, P., AND ROCKETT. K . "Optimal Patent Design and the Diffusion of Innovations." Discussion Paper no. 91-39, Northwestern University, J.L. Kellogg School of Management, 1992.
24. MCGOUGH, K . J . AND BURKE, D . P . " A Case for Expansive Patent Protection of Biotechnology Inventions." Harvard Journal of Law and Technology, Vol. 7 (1992), pp. 85-102.
25. MERGES, R.P. AND NELSON, R.R. "On the Complex Economics of Patent Scope." Columbia Law Review, Vol. 90 (1990), pp. 839-916.
26. National Register Publishing Company (National). Directory of Corporate Affiliations. Wilmette, 111.: National Register Publishing Co., 1992.
27. North Carolina Biotechnology Center, Biotechnology Information Division (NCBC). North Carolina Biotechnology Center Documentation for Actions Database. Research Triangle Park, N.C.: NCBC, 1990a.
28. North Carolina Biotechnology Center Documentation for Companies Database. Research Triangle Park, N.C.: NCBC, 1990b.
29. Ornx Press. BioScan: The Worldwide Biotech Industry Reporting Service. Phoenix, Ariz.: Ornx Press, 1992.
30. PAKES, A . S . "Patents as Options: Some Estimates of the Value of Holding European Patent Stocks." Econometrica, Vol. 54 (1986), pp. 755-784.
31. "Patent Protection Passes Senate." BioWorld Today, July 19, 1993, pp. 1-2.
32. Predicasts, Inc. Predicasts' F&S Index of Corporate Change. Cleveland, Ohio: Predicasts, Inc., 1992.
33. President's Council on Competitiveness. Report on National Biotechnology Policy. Washington, D.C.: President's Council, 1991.
34. Recombinant Capital. Valuation Histories for Private Biotechnology Companies. San Francisco: Recombinant Capital, 1991.
35. Valuation Histories for Public and Acquired Biotechnology Companies. San Francisco: Recombinant Capital , 1992.
36. "Role of Patents in Biotechnology is the Focus of Two Conferences." BNA's Patent, Trademark and Copyright Journal, Vol. 40 (1990). pp. 211-213.
37. SAHLMAN, W.A. "The Structure and Governance of Venture-Capital Organizations." Journal of Financial Economics, Vol. 27 (1990), pp. 473-521.
38. SCOTCHMER, S. "Protecting Early Innovators: Should Second Generation Products be Patentable?" Working Paper no. 183, University of California at Berkeley, Graduate School of Public Policy, 1990.
39. TRAJTENBERG, M . "A Penny for Your Quotes: Patent Citations and the Value of Inventions." RAND Journal of Economics, Vol. 21 (1990), pp. 172-187.
40. U.S. Congress, Office of Technology Assessment (USOTA). New Developments in Biotechnology: Patenting Life. Part 5, Series on New Developments in Biotechnology. Washington, D.C.: Government Printing Office, 1989.
41. U.S. Department of Commerce, Patent Office (USPO). Development and Use of Patent Classification Systems. Washington, D.C.: Government Printing Office, 1966.
42. U.S. Department of Commerce, Patent and Trademark Office. (USPTO). Manual of Patent Examining Procedure. 3d ed.. Revision 30. Washington, D.C.: Government Printing Office, 1971.
43. Examiner Handbook on the Use of the U.S. Patent Classification System. Washington, D.C.: Government Printing Office, 1984.
44. Manual of Patent Examining Procedure. 5th ed., Revision 14. Washington, D.C.: Government Printing Office, 1992.
45. Manual of Classification. Washington, D.C.: Government Printing Office, 1993.
46. U.S. Department of Commerce, Patent and Trademark Office, Office of Patent Depository Library Programs (USPTO/OPDLP). CASSIS/BIB Users Guide. Washington, D.C.: USPTO/OPDLP, 1990.
47. "ASSIST Disk Notes." Mimeo, USPTO/OPDLP, 1991.
48. U.S. General Accounting Office (USGAO). Biotechnology: Backlog of Patent Applications. Washington, D.C.: USGAO, 1989.
49. Biotechnology: Processing Delays Continue for Growing Backlog of Patent Applications. Washington, D.C.: USGAO. 1990.
50. Venture Economics. "Untitled Documentation of Databases." Mimeo, Boston, Mass.: Venture Economics, 1991.
51. World Intellectual Property Organization (WIPO). General Information on the Third Edition of the International Patent Classification. Geneva: World Intellectual Property Organization, 1981.